Didier Raoult Publishes His Second Clinical Trial Of Hydroxychloroquine And Azithromycin On COVID-19
The big and good news continues: This crisis is over and all government edicts must instantly end.
Tuesday, 31 March 2020: World-Renowned microbiologist¬†Didier Raoult¬†has published the results of his second clinical trial of the hydroxychloroquine/azithromycin treatment for COVID-19 with which¬†he and his team had achieved a 100% cure rate¬†earlier this month. This second, larger trial of 80 infected patients again demonstrated that Dr. Raoult’s formulation is a game-changer, and this “COVID-19 crisis”¬†is over.
From the trial report abstract:
In 80 in-patients receiving a combination of hydroxychloroquine and azithromycin, we noted clinical improvement in all but one 86 year-old patient who died, and one 74-year-old patient still in the intensive care unit. A rapid fall of nasopharyngeal viral load tested by qPCR was noted, with 83% negative at Day7, and 93% at Day8. Virus cultures from patient respiratory samples were negative in 97.5% of patients on Day5.
As noted in a commentary on the original trial of Dr. Raoult’s formulation several weeks ago, although Raoult’s addition of azithromycin is new, and has pushed the treatment of the coronavirus to the stature of an actual cure, treatment of COVID-19 victims with hydroxychloroquine alone has long been established in Chinese tests. See, for instance,¬†this report by Manli Wang and the team at the Chinese Academy of Sciences, published February 4, 2020, at nature.com.
DIDIER RAOULT’S follow-up demonstration re-affirming that COVID-19 can be successfully treated– and with inexpensive, widely-available and long-familiar, safe medicines– is most welcome. The American people can now shrug off the mind-killing fear that had taken hold over the last month.
The American people can, and must, also immediately and firmly¬†hit the “reset” button.